Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Pancreatic steatosis: harbinger of type 2 diabetes in obese rodents

Abstract

Objective:

The aim of this study was to determine if the fat accumulation in the exocrine pancreas fat of obese Zucker diabetic fatty (ZDF) rodents, like that in their endocrine pancreas, precedes the onset of type 2 diabetes mellitus (T2DM). As the fat content of whole pancreas, but not islets, can now be measured in humans by magnetic resonance spectroscopy (MRS), such measurements could be used as a predictor of impending T2DM and an indication for preventive intervention.

Animals:

Obese ZDF (fa/fa) rats and lean (+/+) controls on a 6% fat diet were killed at time points from 6 to 16 weeks and total pancreatic fat was measured biochemically and electronmicroscopic examination of tissue for fat droplets was carried out.

Results:

Compared to lean ZDF controls, pancreatic fat was elevated above lean controls from 6 to 16 weeks of age, peaking at 10 weeks of age when hyperglycemia first appeared. The pancreatic profile of fat content in whole pancreas paralleled that of islets. Electronmicroscopic examination identified the acinar location of the fat droplets and ruled out a major contribution of intrapancreatic adipocytes.

Conclusion:

The almost identical pattern of triglyceride overaccumulation in the exocrine and endocrine pancreas of obese rodents before the onset of T2DM suggests that MRS of the human pancreas might predict T2DM in obese subjects and permit timely interventions to prevent the disease.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Ong KL, Cheung BM, Wong LY, Wat NM, Tan KC, Lam KS . Prevalence, treatment, and control of diagnosed diabetes in the US National Health and Nutrition Examination Survey 1999-2004. Ann Epidemiol 2008; 18: 222–229.

    Article  PubMed  Google Scholar 

  2. McGarry JD . Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 2002; 51: 7–18.

    Article  CAS  PubMed  Google Scholar 

  3. Milburn Jr JL, Hirose H, Lee YH, Nagasawa Y, Ogawa A, Ohneda M et al. Pancreatic beta-cells in obesity. Evidence for induction of functional, morphologic, and metabolic abnormalities by increased long chain fatty acids. J Biol Chem 1995; 270: 1295–1299.

    Article  CAS  PubMed  Google Scholar 

  4. Virtue S, Vidal-Puig A . It's not how fat you are, it's what you do with it that counts. PLoS Biol 2008; 6: e237.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Savage DB, Petersen KF, Shulman GI . Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol Rev 2007; 87: 507–520.

    Article  CAS  PubMed  Google Scholar 

  6. Shimabukuro M, Higa M, Zhou YT, Wang MY, Newgard CB, Unger RH . Lipoapoptosis in beta-cells of obese prediabetic fa/fa rats. Role of serine palmitoyltransferase overexpression. J Biol Chem 1998; 273: 32487–32490.

    Article  CAS  PubMed  Google Scholar 

  7. Shimabukuro M, Wang MY, Zhou YT, Newgard CB, Unger RH . Protection again lipoapoptosis of beta cells through leptin-dependent maintenance of Bcl-2 expression. Proc Natl Acad Sci USA 1998; 95: 9558–9561.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Park TS, Hu Y, Noh HL, Drosatos K, Okajima K, Buchanan J et al. Ceramide is a cardiotoxin in lipotoxic cardiomyopathy. J Lipid Res 2008; 49: 2101–2112.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Lee Y, Hirose H, Ohneda M, Johnson JH, McGarry JD, Unger RH . Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships. Proc Natl Acad Sci USA 1994; 91: 10878–10882.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Hirose H, Lee YH, Inman LR, Nagasawa Y, Johnson JH, Unger RH . Defective fatty acid-mediated beta-cell compensation in Zucker diabetic fatty rats. Pathogenic implications for obesity-dependent diabetes. J Biol Chem 1996; 271: 5633–5637.

    Article  CAS  PubMed  Google Scholar 

  11. Dobbins RL, Szczepaniak LS, Myhill J, Tamura Y, Uchino H, Giacca A et al. The composition of dietary fat directly influences glucose-stimulated insulin secretion in rats. Diabetes 2002; 51: 1825–1833.

    Article  CAS  PubMed  Google Scholar 

  12. Tushuizen ME, Bunck MC, Pouwels PJ, Bontemps S, van Waesberghe JH, Schindhelm RK et al. Pancreatic fat content and beta-cell function in men with and without type 2 diabetes. Diabetes Care 2007; 30: 2916–2921.

    Article  CAS  PubMed  Google Scholar 

  13. Lingvay I, Esser V, Legendre JL, Price AL, Wertz KM, Adams-Huet B et al. Noninvasive quantification of pancreatic fat in humans. J Clin Endocrinol Metab 2009; 94: 4070–4076.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Folch J, Lees M, Sloane Stanley GH . A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957; 226: 497–509.

    CAS  PubMed  Google Scholar 

  15. Koyama K, Chen G, Lee Y, Unger RH . Tissue triglycerides, insulin resistance, and insulin production: implications for hyperinsulinemia of obesity. Am J Physiol 1997; 273: E708–E713.

    CAS  PubMed  Google Scholar 

  16. Unger RH, Orci L . Diseases of liporegulation: new perspective on obesity and related disorders. FASEB J 2001; 15: 312–321.

    Article  CAS  PubMed  Google Scholar 

  17. Pinnick KE, Collins SC, Londos C, Gauguier D, Clark A, Fielding BA . Pancreatic ectopic fat is characterized by adipocyte infiltration and altered lipid composition. Obesity (Silver Spring) 2008; 16: 522–530.

    Article  CAS  Google Scholar 

  18. Shimabukuro M, Zhou YT, Lee Y, Unger RH . Troglizatone lowers islet fat and restores beta cell function of Zucker diabetic fatty rats. J Biol Chem 1998; 273: 3547–3550.

    Article  CAS  PubMed  Google Scholar 

  19. Hays NP, Galassetti PR, Coker RH . Prevention and treatment of type 2 diabetes: current role of lifestyle, natural product, and pharmacological interventions. Pharmacol Ther 2008; 118: 181–191.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Lee Y, Wang MY, Kakuma T, Wang ZW, Babcock E, McCorkle K et al. Liporegulation in diet-induced obesity. The antisteatotic role of hyperleptinemia. J Biol Chem 2001; 276: 5629–5635.

    Article  CAS  PubMed  Google Scholar 

  21. Ohneda M, Inman LR, Unger RH . Caloric restriction in obese pre-diabetic rats prevents beta-cell depletion, loss of beta-cell GLUT 2 and glucose incompetence. Diabetologia 1995; 38: 173–179.

    Article  CAS  PubMed  Google Scholar 

  22. Yu X, McCorkle S, Wang M, Lee Y, Li J, Saha AK et al. Leptinomimetic effects of the AMP kinase activator AICAR in leptin-resistant rats: prevention of diabetes and ectopic lipic deposition. Diabetologia 2004; 47: 2012–2021.

    Article  CAS  PubMed  Google Scholar 

  23. Sreenan S, Sturis J, Pugh W, Burant CF, Polonsky KS . Prevention of hyperglycemia in the Zucker diabetic fatty rat by treatment with metformin or troglitazone. Am J Physiol 1996; 271: E742–E747.

    Article  CAS  PubMed  Google Scholar 

  24. Higa M, Zhou YT, Ravazzola M, Baetens D, Orci L, Unger RH . Troglitazone prevents mitochondrial alterations, beta cell destruction, and diabetes in obese prediabetic rats. Proc Natl Acad Sci USA 1999; 96: 11513–11518.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Unger RH . Reinventing type 2 diabetes: pathogenesis, treatment, and prevention. JAMA 2008; 299: 1185–1187.

    Article  CAS  PubMed  Google Scholar 

  26. Crandall JP, Knowler WC, Kahn SE, Marrero D, Florez JC, Bray GA et al. The prevention of type 2 diabetes. Nat Clin Pract Endocrinol Metab 2008; 4: 382–393.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Liberopoulos EN, Mikhailidis DP, Elisaf MS . Diagnosis and management of the metabolic syndrome in obesity. Obes Rev 2005; 6: 283–296.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank the Pole Facultaire de Microscopie Ultrastructurale and the Service Facultaire d’Histologie of Geneva Medical School who kindly provided access to microscopy equipment. Part of this work was financially supported by NIH CTSA Grant UL1 RR024982. ILL was supported by a Doris Duke Charitable Foundation clinical research fellowship. LSS was supported by NIH K25 HL-68736. YL and RHU were supported by NIH Grant R01 DK002700 and the Department of Veterans Affairs Merit Review. LO was supported by the Swiss National Science Foundation. S Kay McCorkle and Peggy McCravy prepared the paper.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R H Unger.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, Y., Lingvay, I., Szczepaniak, L. et al. Pancreatic steatosis: harbinger of type 2 diabetes in obese rodents. Int J Obes 34, 396–400 (2010). https://doi.org/10.1038/ijo.2009.245

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ijo.2009.245

Keywords

This article is cited by

Search

Quick links